Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Alkermes (ALKS)

Alkermes raises 2025 outlook as Q3 revenue rises 4% but quarterly profit falls

Mixed Impact 4 of 5 earnings Written later

Alkermes reported third-quarter 2025 total revenues of $394.2 million, up from $378.1 million a year earlier, while GAAP net income fell to $82.8 million, or $0.49 per diluted share, from $92.4 million, or $0.55 per diluted share, in the prior-year quarter. The company raised its 2025 expectations, including total revenues of $1,430 million to $1,490 million and GAAP net income of $230 million to $250 million, and the filing notes the proposed acquisition of Avadel Pharmaceuticals announced the prior week.

Key points

  • Q3 2025 total revenues were $394.2 million vs. $378.1 million in Q3 2024; LYBALVI revenues were $98.2 million, up 32%.
  • GAAP net income was $82.8 million ($0.49 diluted EPS) vs. $92.4 million ($0.55 diluted EPS) in Q3 2024.
  • 2025 total revenue guidance raised to $1,430 million to $1,490 million from $1,340 million to $1,430 million; GAAP net income guidance raised to $230 million to $250 million from $175 million to $205 million.
  • Cash, cash equivalents and total investments were $1.14 billion at Sept. 30, 2025, vs. $1.05 billion at June 30, 2025.

The filing

CompanyAlkermes (ALKS)
Form8-K, current report
Filed with the SECOct 28, 2025, 7:05 AM ET
Accession number0001193125-25-252207

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.